Loading data
XXIINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | 32.2 m USD | 40.5 m USD | 30.95 m USD |
| Cost of revenue | 10.19 m USD | 14.28 m USD | — | — | — |
| Research and development expense | 688 k USD | 1.13 m USD | 2.64 m USD | 3.58 m USD | 3.91 m USD |
| Selling, general and administrative expense | 7.59 m USD | 10.29 m USD | 31.06 m USD | 32.23 m USD | 25.91 m USD |
| Operating profit | -11.57 m USD | -13.95 m USD | -44.93 m USD | -33.64 m USD | -28.41 m USD |
| Interest expense | — | — | 9.37 m USD | 55 k USD | 58 k USD |
| Profit before tax | -13.15 m USD | -15.47 m USD | -54.64 m USD | -36.53 m USD | -32.6 m USD |
| Income tax expense | -28 k USD | 30 k USD | 47 k USD | 21 k USD | 14 k USD |
| Net income (reported basis) | -5.05 m USD | -15.16 m USD | -140.78 m USD | -59.8 m USD | -32.61 m USD |
| Net income attributable to common shareholders | -9.73 m USD | -25.47 m USD | -150.77 m USD | -59.8 m USD | — |
| Basic earnings per share | -52.87 USD/share | -45,711.05 USD/share | -15,925.99 USD/share | -4.65 USD/share | -0.21 USD/share |
| Diluted earnings per share | -52.87 USD/share | -45,711.05 USD/share | -15,925.99 USD/share | -4.65 USD/share | -0.21 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.